A case of acute myocardial infarction in a working-age patient with ulcerative colitis against the background of late initiation of pathogenetic therapy

Larisa V. Tarasova , Nadezhda Yu. Kucherova , Julia V. Tsyganova

For citation:

Abstract

The article describes a case of acute myocardial infarction with multiple atherosclerotic lesions of the coronary arteries in a working-age patient with ulcerative colitis, against of late initiation of pathogenetic therapy.
Key words: inflammatory bowel diseases, atherosclerosis, acute myocardial infarction, ulcerative colitis.

References

1. Zhao M, Gonczi L, Lakatos PL, Burisch J. The durden of inflammatory dowel disease in europe in 2020. J Crohns Colitis. 2021; 15 (9): 1573–87. DOI: 10.1093/ecco-jcc/jjab029

2. Chen B, Collen LV, Mowat C et al. Inflammatory bowel disease and cardiovascular diseases. Am J Med. 2022; 135 (12): 1453–60. DOI: 10.1016/j.amjmed.2022.08.012

3. Федеральная служба государственной статистики. Доступ: https://rosstat.gov.ru/sdg/data/goal3 (дата обращения – 01.08.2023).

Federal State Statistics Service (Russia). URL: https://rosstat.gov.ru/ sdg/data/goal3 (date of access – 01.08.2023) (in Russian).

4. Nguyen NH, Ohno-Machado L, Sandborn WJ, Singh S. Infections and cardiovascular complications are common causes for hospitalization in jlder patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2018; 24 (4): 916–23. DOI: 10.1093/ibd/izx089

5. Weissman S, Sinh P, Mehta TI et al. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation. World J Gastrointest Pathophysiol. 2020; 11 (5): 104–13. DOI: 10.4291/wjgp.v11.i5.104

6. Czubkowski P, Osiecki M, Szymańska E, Kierkuś J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med. 2020; 20 (4): 481–91. DOI: 10.1007/s10238-020-00639-y

7. Qu C, Cao J, Liu K et al. Crohn's disease complicated with extensive thrombosis of limbs and mesenteric arteries: A case report and literature review. Ann Vasc Surg. 2019; 58: 382.e15-382.e19. DOI: 10.1016/j.avsg.2018.12.079

8. Kristensen SL, Ahlehoff O, Lindhardsen J et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death-a Danish nationwide cohort study. PLoS One. 2013; 8 (2): e56944. DOI: 10.1371/journal.pone.0056944

9. Singh S, Singh H, Loftus EV, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014; 12: 382–393. DOI: 10.1016/j.cgh.2013.08.023

10. Aniwan S, Pardi DS, Tremaine WJ et al. Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018; 16 (10): 1607–15. DOI: 0.1016/j.cgh.2018.04.031

11. Миронова О.Ю., Исайкина М.А., Хасиева С.А. Атеросклероз и сердечно-сосудистый риск у пациентов с воспалительными заболеваниями кишечника. Терапевтический архив. 2021; 93 (12): 1533–8.

Mironova OI, Isaikina MA, Khasieva SA. Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease. Therapeutic Archive. 2021; 93 (12): 1533–38. DOI: 10.26442/00403660.2021. 12.201225 (in Russian).

12. Бабаева Г.Г., Бабаев З.М. Частота выявления некоторых маркеров эндотелиальной дисфункции у больных с воспалительными заболеваниями кишечника. Терапевтический архив. 2018; 90 (4): 12–6.

Babayeva GH, Babayeva ZM. Frequency of detection of some markers of endothelial dysfunction in patients with inflammatory bowel diseases. Therapeutic Archive. 2018; 90 (4): 12–16. DOI: 10.26442/terarkh201890412-16 (in Russian).

13. Dowsett L, Higgins E, Alanazi S et al. ADMA: а key player in the relationship between vascular dysfunction and inflammation in atherosclerosis. J Clin Med. 2020; 9 (9): 3026. DOI: 10.3390/jcm9093026

14. Гриневич В.Б., Радченко В.Г. Микробиота кишечника и метаболический синдром. Экспериментальная и клиническая гастроэнтерология. 2020;183(11):11–19.

Grinevich VB, Radchenko VG. Gut microbiota and metabolic syndrome. Experimental and Clinical Gastroenterology. 2020;183(11): 11–19. DOI: 10.31146/1682-8658-ecg-183-11-11-19 (in Russian).

15. Lee MT, Mahtta D, Chen L et al. Premature atherosclerotic cardiovascular disease Risk among patients with inflammatory bowel disease. Am J Med. 2021 Aug; 134 (8): 1047–51. DOI: 10.1016/j.amjmed. 2021.02.029

16. Xiao Y, Powell DW, Liu X, Li Q. Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms. Am J Physiol Regul Integr Comp Physiol. 2023; 325 (2): 193–211. DOI: 10.1152/ajpregu.00300.2022

17. Troseid M, Andersen GO, Broch K, Hov JR. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine. 2020; 52: 102649. DOI: 10.1016/ j.ebiom.2020.102649

For citation:Tarasova L.V., Kucherova N.Yu., Tsyganova Ju.V. A case of acute myocardial infarction in a working-age patient with ulcerative colitis against the background of late initiation of pathogenetic therapy. Clinical review for general practice. 2023; 4 (7): 30–34 (In Russ.). DOI: 10.47407/kr2023.4.7.00283

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice